These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26994580)

  • 1. The Case | The young philosopher with multiple sclerosis and proteinuria.
    Piccoli GB; Capobianco M; Vigotti FN; Naretto C; Narioz C; Brocheriou I; Roccatello D
    Kidney Int; 2016 Apr; 89(4):961-3. PubMed ID: 26994580
    [No Abstract]   [Full Text] [Related]  

  • 2. Case report of thrombotic microangiopathy associated with subcutaneous interferon beta-1a: an emerging complication?
    Azkune Calle I; Sánchez Menoyo JL; Ruiz Ojeda J; García Moncó JC; Etxeguren Urkixo I
    Neurologia; 2016 Sep; 31(7):508-9. PubMed ID: 25449964
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.
    Mahe J; Meurette A; Moreau A; Vercel C; Jolliet P
    Drug Des Devel Ther; 2013; 7():723-8. PubMed ID: 23950639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
    Viana de Andrade AC; Brito ÉA; Harris OM; Viana de Andrade AP; Leite MF; Pithon MM
    Int J Dermatol; 2015; 54(5):e140-5. PubMed ID: 25208461
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on thrombotic microangiopathy induced by interferon-β therapy.
    Cavoli GL; Passantino R; Tortorici C; Bono L; Ferrantelli A; Rotolo U
    Clin Nephrol; 2012 Dec; 78(6):506-7. PubMed ID: 23164420
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report.
    Broughton A; Cosyns JP; Jadoul M
    Clin Nephrol; 2011 Nov; 76(5):396-400. PubMed ID: 22000560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.
    Ozturk M; Basoglu F; Yilmaz M; Ozagari AA; Baybas S
    Mult Scler Relat Disord; 2016 Sep; 9():50-3. PubMed ID: 27645343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Respiratory Failure Due to Interferon Beta-Related Pulmonary Hypertension.
    Piroddi IM; Barlascini C; Nicolini A
    Am J Ther; 2016; 23(5):e1275-6. PubMed ID: 26561952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.
    Kozielewicz D; Pawłowska M
    Neurol Neurochir Pol; 2015; 49(6):451-5. PubMed ID: 26652882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon beta retinopathy in a patient with multiple sclerosis.
    Post JW; Colleaux K
    Can J Ophthalmol; 2009 Oct; 44(5):e37. PubMed ID: 19798812
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon ß, nephrotic syndrome and thrombotic microangiopathy].
    Quintana LF; Campistol JM
    Med Clin (Barc); 2015 Jan; 144(2):65-6. PubMed ID: 25458512
    [No Abstract]   [Full Text] [Related]  

  • 12. Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis?
    Langeskov-Christensen M; Kjølhede T; Stenager E; Jensen HB; Dalgas U
    J Neurol Sci; 2016 Jun; 365():114-20. PubMed ID: 27206886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid-Onset Psychotic Symptoms After Interferon-β-1a Treatment of Multiple Sclerosis.
    Huang JS; Chang CC; Tai YM; Huang CP; Chen SJ; Tzeng NS
    Am J Ther; 2020; 27(6):e631-e632. PubMed ID: 31232706
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-beta in multiple sclerosis causing thrombotic microangiopathy.
    Yam C; Fok A; Mclean C; Butler E; Kempster P
    Intern Med J; 2019 Feb; 49(2):274-276. PubMed ID: 30754081
    [No Abstract]   [Full Text] [Related]  

  • 15. Subacute thyroiditis in a patient with MS treated with interferon beta-1a.
    Kreiss Y; Cohen O; Pras E; Achiron A
    Neurology; 1999 Oct; 53(7):1606. PubMed ID: 10534282
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
    Strohm T; Chaudhry B; Willis MA; Shook S
    Mult Scler; 2016 Oct; 22(12):1626-1628. PubMed ID: 27012659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy.
    Lehmann HC; Krüger K; Fink GR; Schroeter M
    J Neurol; 2015 Mar; 262(3):771-3. PubMed ID: 25578178
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
    Duchini A
    Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
    Kocer B; Nazliel B; Oztas M; Batur HZ
    Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
    [No Abstract]   [Full Text] [Related]  

  • 20. [Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region].
    Spirin NN; Kasatkin DS; Stepanov IO; Shipova EG; Baranova NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):27-33. PubMed ID: 23096035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.